Target cut hits ALNY
Alnylam is selling off violently after an analyst cut its price target, adding to pressure on the stock with no broad market move large enough to explain the drop.
Sources: https://www.tradingview.com/news/reuters.com,2026:newsml_L8N45M20O:0/, https://www.moomoo.com/hans/news/post/1000477958/alnylam-pharmaceuticals-price-target-cut-to-369-00-share-from, htt
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works